Global Hematology Analyzers Market Size By Product And Services (Instruments, Reagents & Consumables, Services), By End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories), By Geographic Scope And Forecast

Hematology Analyzers Market Size And Forecast

Hematology Analyzers Market size was valued at USD 7.50 Billion in 2020 and is projected to reach USD 12.39 Billion by 2028, growing at a CAGR of 6.37% from 2021 to 2028. 

The Global Hematology Analyzers Market is growing due to the increasing prevalence of blood-related disorders. Hematology technology is still in its infancy in the world of healthcare, but it has come a long way in terms of application and usability. Blood samples are analyzed using hematology analyzers, which count white blood cells and perform reticulocyte analysis. The Global Hematology Analyzers Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Hematology Analyzers Market Definition

Hematology analyzers are devices that are used to do a full blood test. These are the most common tests performed during a check-up. The majority of hematology analyzers now include an integrated reticulocyte count analysis with the routine complete blood count analysis, which not only provides reticulocyte percent and absolute reticulocyte counts, but also additional data such as reticulocyte hemoglobin content (CHr), percent hypochromic cells, percent microcytic cell or microcytic anemia factor, immature reticulocyte fraction, and so on. The degree of hemo globalization in maturing erythroid precursors is reflected by CHr, which is a measure of total hemoglobin content in a reticulocyte expressed in pg.

According to (NCBI) National Center for Biotechnology Information, CHr is a useful measure that indicates the availability of functional iron for erythropoiesis over the previous 3–4 days. CHr has been shown to be a sensitive indicator of iron deficiency erythropoiesis. The readings of 27 pg are very suggestive of anemia due to iron deficiency. Similarly, determining the percent hypochromic (defined as the percentage of red cells with a hemoglobin concentration of less than 28 g/dl on Siemens and Advia systems and less than 17 pg on Sysmex analyzers) is a sensitive indicator for determining the hemo globalization of mature red cells.

The presence of more than 10% hypochromic red cells in all RBCs is highly suggestive of iron deficiency anemia. Current analyzers provide a five- to seven-part differential white-cell examination using various technologies such as electrical impedance, radiofrequency conductivity, light scatter, fluorescence scatter, cytochemistry, and so on. They also provide additional information in the form of cell population statistics and the Lymph Index Granularity Index, as well as large unstained cell populations and hemiparasites, which can be used to screen for benign and malignant hematological disorders. For each unique white cell subtype, CPD is created during the white-cell differential analysis using VCS technology.

Following the lysis of red cells, the Coulter hematology analyzer’s VCS technology can obtain data from >8000 white blood cells in their near-native state in a few seconds, using impedance to measure cell volume for accurate size of all cell types, radiofrequency opacity to characterize conductivity for inner composition-nuclear volume, nuclear-cytoplasmic details of each cell and nuclear lobulations, and a beam to measure light scatter for cytoplasmic.

Global Hematology Analyzers Market Overview

Increasing levels of blood donation activities, as well as an increase in the incidence of blood disorders in patients, are driving product demand; this aspect is projected to propel the market forward. The market is predicted to develop due to the adoption of the product in conjunction with flow cytometry processes. The introduction of automated analyzers has resulted in a significant reduction in the time it takes to complete a test and an increase in manifold efficiency. The rising prevalence of disorders such as anemia and leukemia is expected to boost the market even more. People’s disposable income has risen over the world, resulting in more healthcare spending.

The growth of commercial testing centers has expanded testing capacity dramatically. Some of the primary drivers driving the market include a rise in disposable income, an increase in cases of diseases like Leukemia, and technological improvements. Technological advances have resulted in the development of fully automated 3-part and 5-part hematology analyzers. These analyzers are completely self-contained. The 3-part automatic analyzer is a little less expensive than the other options. Furthermore, several governments are investing in healthcare sectors in order to strengthen the industry, which would lead to the establishment of new testing centers. Restraints- The market is expected to be restrained by the high cost of hematology analyzers, as well as strict reimbursement rules.

Hematology analyzers can be prohibitively expensive for small and mid-sized businesses, as a result. Furthermore, several insurance companies have tightened their reimbursement procedures significantly. As a result, certain segments of the population are unable to receive medical treatment. These factors are expected to be growth inhibitors. Likewise, a three-part differential cell counter uses Coulter’s Principle to determine the cell’s size and volume. In a container that also holds a smaller container, the sample is lysed and dissolved in an electrolyte solution. 3-part hematology analyzer systems are excellent for moderately sophisticated testing in physician office laboratories, clinics, and small hospitals. Although 5-part hematology analyzers are gaining popularity, 3-part hematology analyzers are more cost-effective for typical hematological examinations.

The centers where hematological tests are performed are referred to as clinical laboratories as end-users. They usually use high-quality equipment, and the findings they provide are reliable. The automation of laboratories has raised the expense of equipment in this market, yet analyzers are not routinely updated in these labs. Clinical testing laboratories analyze whole blood, serum, urine, cerebrospinal fluids, and other bodily fluids. According to (CDC), Centers for Disease Control and Prevention Blood pressure will be measured using an Omron IntelliSense Blood Pressure Monitor (ModelHEM-907XL). The Omron BP monitor was designed to precisely and quickly detect blood pressure and pulse rate in a clinical context.

Global Hematology Analyzers Market Segmentation Analysis

The Global Hematology Analyzers Market Is Segmented On The Basis Of Product And Services, End User, and Geography.

Hematology Analyzers Market, By Product And Services

• Instruments• Reagents & Consumables• Services

Based on Product And Services, the market is segmented into Instruments, Reagents & Consumables, and Services. Instruments are further divided into 5- and 6-part Fully Automated Hematology Analyzers, 3-part Completely Automated Hematology Analyzers, Point-of-Care Testing Hematology Analyzers, and Moderately Hematology Analyzers under the Instruments section. Hematology Reagents, Side Stainers/Makers, Controls and Calibrators, and Consumables make up the Reagents & Consumables section. All of the segments are expected to increase significantly.

This is due to the growing popularity of these instruments around the world. Blood samples are tested using hematology analyzers. White blood cell counts, complete blood counts, reticulocyte analysis, and coagulation tests are all done with them in the medical sector. Animals and human blood hematology analyzers are accessible, making them suitable for veterinarians, zoos, and research organizations. Closed vial testing and open sampling testing are two features that differ from one hematological analyzer to the next.

Hematology Analyzers Market, By End User

• Hospital Laboratories• Commercial Service Providers• Government Reference Laboratories• Research & Academic Institutes

Based on End User, the market is segmented into Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, and Research & Academic Institutes. Several automated analyzers at a clinical laboratory in a hospital setting. A medical laboratory, also known as a clinical laboratory, is a facility that conducts tests on clinical specimens in order to gain information about a patient’s health and aid in the diagnosis, treatment, and prevention of disease. The Commercial Service Provider category is expected to hold the majority of the market. This is due to an increase in the number of cases of diseases such as leukemia, as well as a transition from manual to automated testing procedures. In comparison to hospital laboratories, commercial service providers provide additional benefits and advantages.

Hematology Analyzers Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, the Global Hematology Analyzers Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The Asia Pacific region is expected to show positive growth during the forecast period. This is primarily due to the increasing prevalence of blood-related disorders. Hematology technology is still in its infancy in the world of healthcare, but it has come a long way in terms of application and usability. Blood samples are analyzed using hematology analyzers, which count white blood cells and perform reticulocyte analysis.

Key Players

The “Global Hematology Analyzers Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories, Boule Diagnostics AB, Hoffmann-La Roche Ltd, Horiba Ltd., Nihon Kohden Corporation, Mindray Medical International Limited, Siemens Healthineers, and Sysmex Corporation. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• February 2018, McKesson and Sysmex have signed a distribution deal for Sysmex’s XW-100 automated hematology analyzers in the United States.

• February 2021, Beckman Coulter has announced the availability of the DxH 560 AL, a tabletop hematology analyzer.

• April 2, 2020, Siemens Healthineers revealed that the FDA has approved the RapidPoint 500e Blood Gas Analyzer.

• Dec 21, 2020, Nihon Kohden has released MEK-1305 Celltac+, an Automated Hematology, and ESR Analyzer, in the international markets

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.